Перегляд за автором "Vislovukh, A.A."

Результати 1-7 з 7

Characterization of novel peptide-specific antibodies against the translation elongation factor eEF1A2 and their application for cancer research

Shalak, V.F.; Vislovukh, A.A.; Novosylna, O.V.; Khoruzhenko, A.I.; Kovalenko, M.I.; Kolesanova, E.F.; Egorova, E.A.; Mishin, A.A.; Krotevych, M.S.; Skoroda, L.V.; Negrutskii, B.S. (Вiopolymers and Cell, 2014)

Aim. We intend to characterize the new peptide-specific antibodies against the isoform 2 of translation elongation factor 1A (eEF1A2) and determine its presence in the postoperative samples of human breast, lung and stomach ...
Control of the amount and functionality of the eEF1A1 and eEF1A2 isoforms in mammalian cells

Negrutskii, B.S.; Novosylna, O.V.; Porubleva, L.V.; Vislovukh, A.A. (Вiopolymers and Cell, 2018)

Aim. To review mechanisms of regulation of expression and the functionality of two isoforms of translation elongation factor eEF1A in mammalian cells. Results. eEF1A1 and eEF1A2 proteins are regulated by post-translational ...
Isoforms of elongation factor eEF1A may be differently regulated at post-transcriptional level in breast cancer progression

Vislovukh, A.A.; Naumovets, M.G.; Kovalenko, M.I.; Groisman, R.S.; Groisman, I.S.; Negrutskii, B.S.; El'skaya, A.V. (Вiopolymers and Cell, 2013)

Eukaryotic translation elongation factor 1A exists as two 98 % homologous isoforms: eEF1A1 (A1) and eEF1A2 (A2) which are tissue and development specific. Despite high homology in an open reading frame (ORF) region, mRNAs ...
mRNAs coding for A1 and A2 isoforms of translation factor eEF1A demonstrate different half-lives while A1 and A2 proteins are similarly stable in MCF7 cells

Vislovukh, A.A.; Gralievska, N.L.; Naumovets, M.G.; Negrutskii, B.S.; El'skaya, A.V. (Вiopolymers and Cell, 2013)

Eukaryotic translation elongation factor 1A (eEF1A) exists as two 98 % homologous isoforms eEF1A1 and eEF1A2 that are tissue/development specific and differentially linked to apoptosis/cancerogenesis. A2 is overexpressed ...
PTI-1: novel way to oncogenicity

Vislovukh, A.A.; Shalak, V.F.; Savytskyi, O.V.; Kovalenko, N.I.; Gralievska, N.L.; Negrutskii, B.S.; El’skaya, A.V. (Вiopolymers and Cell, 2012)

Aim. The prostate tumor-inducing oncogene (PTI-1), presumably encoding a truncated form of eukaryotic translation elongation factor 1A1 (eEF1A1), was discovered as a gene overexpressed in prostate tumor samples and absent ...
Specific features of protein biosynthesis in higher eukaryotes

El'skaya, A.V.; Negrutskii, B.S.; Shalak, V.F.; Vislovukh, A.A.; Vlasenko, D.O.; Novosylna, A.V.; Lukash, T.O.; Veremieva, M.V. (Вiopolymers and Cell, 2013)

Over 40 years of studies in the field of higher eukaryotic translation are summarized in the review. Among the pioneer results obtained we should especially accentuate the following: i) discovery of the adaptation of tRNAs ...
Transcriptional and post-transcriptional control of eEF1A2 expression during myoblast diffrerentiation

Vislovukh, A.A.; Groisman, I.S.; El’skaya, A.V.; Negrutskii, B.S.; Polesskaya, A.N. (Вiopolymers and Cell, 2012)

During postnatal development, the switch of the expression from isoform A1 to the isoform A2 of eukaryotic translation elongation factor (eEF1A) is observed in neuronal and muscle tissues. The switch of the expression is ...

Результати 1-7 з 7

Пошук

Розширений пошук

Перегляд

Вся бібліотека

Перегляд за автором "Vislovukh, A.A."

Репозиторій DSpace/Manakin

Перегляд за автором "Vislovukh, A.A."

Пошук

Перегляд

Вся бібліотека

Мій обліковий запис